Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-11-09FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s generic amoxicillin and clavulanate potassium under an Original Application.
-
FDA approval · 2007-10-17FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Clarithromycin submitted by Sandoz Inc, granting a supplemental approval for the product.
-
FDA approval · 2007-09-07FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for cefdinir, updating the approved labeling for the product.
-
CLINICAL_TRIALS trial_result · 2007-08-31Clinical Trial Update: Efects of Noninvasive Mechanical Ventilation and Conventional Mechanical Ventilation in Patients With Severe Comunity Pneumonia [NA]
A clinical trial comparing noninvasive ventilation to conventional mechanical ventilation in severe community-acquired pneumonia with acute …
-
FDA approval · 2007-08-20FDA Approved: CLARITHROMYCIN — Original Application (Chartwell RX, LLC.)
FDA approved a generic version of clarithromycin from Chartwell RX, LLC through an Original Abbreviated New Drug Application (ANDA).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-08-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's amoxicillin/clavulanate potassium as an Original Application (ANDA), granting approval for a generic antibiotic pr…
-
CLINICAL_TRIALS trial_result · 2007-06-21Clinical Trial Update: Feasibility and Outcomes of Older Patients Hospitalization [NA]
This clinical trial update describes the feasibility and outcomes of hospitalization among older patients. It lists conditions studied, incl…
-
FDA approval · 2007-05-09FDA Approved: CEFDINIR — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's cefdinir product CEFDINIR under an Original Application (ANDA). This generic antibiotic is approved for common infection…
-
FDA approval · 2007-05-07FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for CEFDINIR, a generic cefdinir product, authorizing continued/expanded ma…
-
FDA approval · 2007-05-04FDA Approved: CEFDINIR — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's original application for CEFDINIR (cefdinir), a generic cephalosporin antibiotic.
-
FDA approval · 2007-04-26FDA Approved: LINEZOLID — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for LINEZOLID submitted by Mylan Pharmaceuticals Inc., associated with updates to the product’s …
-
FDA approval · 2007-04-06FDA Approved: CEFDINIR — Original Application (Sandoz Inc)
FDA approved Sandoz's original ANDA for cefdinir, a generic cephalosporin antibiotic.
-
FDA approval · 2007-04-03FDA Approved: TYGACIL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for TYGACIL (tigecycline) by Wyeth Pharmaceuticals (a Pfizer subsidiary), indicating regulatory …
-
CLINICAL_TRIALS research · 2006-10-20Clinical Trial Update: Epidemiology of Community Acquired Pneumonia in North Israel
This is a clinical trial studying the epidemiology of community-acquired pneumonia in North Israel, sponsored by HaEmek Medical Center.
-
CLINICAL_TRIALS research · 2006-09-19Clinical Trial Update: Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia [Phase 2]
A Phase 2 randomized study comparing EDP-420 to a comparator antibiotic for community-acquired pneumonia, sponsored by Enanta Pharmaceutical…
-
FDA approval · 2006-06-19FDA Approved: AMOXICILLIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc. to market amoxicillin under an Original Application (ANDA). The approval covers a generic amoxic…